Skip to content

Clinical trials

Phase 1 Biliary Tract Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Biliary Tract Neoplasms Phase: Phase 1 Country / region: Japan Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20112
20121
20132
20151
20171
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kansai Hepatobiliary Oncology Group3
AstraZeneca2
ASLAN Pharmaceuticals1
AbbVie1
Eli Lilly and Company1
GlaxoSmithKline1
Taiho Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Biliary Tract Neoplasms10
Carcinoma, Non-Small-Cell Lung3
Squamous Cell Carcinoma of Head and Neck2
Carcinoma, Hepatocellular1
Carcinoma, Transitional Cell1
Colorectal Neoplasms1
Esophageal Neoplasms1
Esophageal Squamous Cell Carcinoma1
Head and Neck Neoplasms1
Neoplasm Metastasis1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.